1

Supplemental Appendix 1. Clinical Research File

Preoperative versus postoperativeinitiation of thromboprophylaxis. Effect on coagulation, fibrinolysis, and bleeding in patients undergoing cemented THA.

Patient ID:

Number of randomization:

Signature:

Aims of the study:

To see if there are any clinically significant differences in (1)blood loss and (2)bleeding events and blood transfusions comparing preoperative with postoperative initiation of thromboprophylaxis.

Hospitalization Day1:

1.Date(dd/mm/year):______

2. Gender (F/M):Female/ male

3. Height(cm):______cm

4. Weight(kg):______kg

5. Body mass index (BMI = weight/heightx height): ______kg/m 2

Inclusion: YesNo

Primary coxarthrosis 

50 years or older

Cemented Exeter THA

Signed written consent and patient information 

Exclusion: YesNo

Bleeding disorder or bleeding tendency

Coagulation disorder 

History of venous thromboembolism, deep venous thrombosis, or pulmonary embolism  

NSAIDSwitha half-life of 18hours or moreduring last week  

Active malignancy

Myocardial infarction last 3 months

Stroke last 3 months

Major trauma last 3 months

Chronic lung disease  

Allergy to low molecular-weight heparin

Alcohol or drug abuse

Liverdisease

Renal failure

Concomitant disease:

Medication:

Laboratory testsDay 1:

Hemoglobin (g/dL): _____

Hematocrit(%):_____

Thrombocytes:_____

C reactive protein (mg/dL):_____

Creatinine:_____

Aspartate amino transferase (ASAT)

Alanine amino transferase (ALAT): _____

Preoperative injection:

Date (dd/mm/year):______Time (hours:minutes):______

Day of surgery -Day 0:

Date (dd/mm/year):______

Surgery:

Operation start:______

Operationend:______

Operation time(minutes):______

Perioperative bleeding (mL):______

Fluids during surgery (mL):

Voluven (mL):______

Glucose (mL):______

Ringer (mL):______

Other (mL):_____

Units of packed red blood cells:______

1. PostoperativeFragmin injection(hours/mm):______

.

Hemoglobin (g/dL): ______

Hematocrit (%):______

Until 1 postoperative injection

Fluids in drain (mL):______

Fluids transfused (mL):

Glucose:_____

Voluven:_____

Ringer:_____

Other:_____

Units of packed red blood cells:______

Bleeding events or other adverse events:YesNo

(definitions page10) If yes,complete report adverse event.

Day after surgery- Day 1:

Date (dd/mm/year):_____

Drain removed – Time (hours:minutes): _____

Hemoglobin (g/dL):_____

Hematocrit: (%)_____

Fluids in drain (mL) _____

Fluids transfused(mL):

Glucose:_____

Voluven:_____

Ringer:_____

Other: _____

Units of packed red blood cells:_____

Total perioperativeand postoperative bleeding (mL)_____

Bleeding events or other adverse events: YesNo

(definitions page10). If yes,complete report adverse event.

Postoperative Days – Days 2-5:

Date (dd/mm/year):_____

Hemoglobin (g/dL):_____

Hematocrit: (%)_____

C- reactive protein (CRP):_____

Fluids transfused (mL)

Glucose:_____

Voluven:_____

Ringer:_____

Other:_____

Unitspacked red blood cells _____

Bleeding events or other adverse events: YesNo

(definitions page10). If yes,complete report adverse event.

Postoperative Day6:

Date (dd/mm/year):_____

Hemoglobin (g/dL):_____

Hematocrit: (%)_____

C reactive protein:_____

Fluids transfused (mL)

Glucose:_____

Voluven:_____

Ringer:_____

Other:_____

Units packed red blood cells _____

Bleeding events or other adverse events: YesNo

(definitions page10). If yes,complete report adverse event.

Last day of hospitalization:

Date (dd/mm/year):_____

Number of days including day of surgery:_____

Medication during hospitalization:

Fluids transfused during hospitalization- total (mL):

Voluven: ______

Ringer: ______

Glucose: ______

Other:______

Units packed red blood cells transfused during hospitalization- total______

Adverse events during hospitalization

(definitions on page10) Yes No

If yes, what kind of adverse event:

Bleeding events:Yes No

Thromboembolic events:Yes No

Other complications: Yes No

If Yes, complete report adverse event.

Followup 6 months:

Thrombolic events:

Pulmonary embolism (PE)

Deep venous thrombosis (DVT)

Transitory ischemic attack (TIA)

Thrombosis/embolus ofcentral nervous system (CNS)and retinal vessels

Ischemic heart disease

Postthrombotic syndrome– pain, tenderness, and swollen leg

Postoperative confusion

Other possible thromboembolic events

Bleeding events:

Hematoma at injection siteor hip

Prolonged secretion

Excessive bleeding leading to reoperation

Central nervous system bleeding

Gastrointestinal bleeding

Hematuria

Other bleeding events

Other complications:

Allergic reactions

Peripheral nerve injury

Pneumonia

Dislocation of hip

Superficial wound infection

Deep infection

Reoperation

Readmission to hospital

Other disease diagnosed after surgery and until followup

Definitions:

Adjudicated clinical bleeding events

Serious / Moderate / Mild
Bleeding intocentral nervous system / Spontaneous skin hematoma≥25 cm / Any other bleeding event
Retroperitoneal bleeding / Wound hematoma≥ 100cm
Fatal bleeding / Spontaneous nose bleed≥ 5 minutes
Bleeding causing treatment cessation / Spontaneous macroscopic hematuria
Bleeding causing reoperation / Spontaneous rectal bleeding more than spot on toilet paper
Gingival bleeding ≥ 5 minutes

REPORT - ADVERSE EVENTS:

Patient number:______Randomization number:______

Type of event: ______

Date event:______

Treatment event:______

Result of treatment:______

New followup/date:______

______

1